Dyspnoea relief as an inherent benefit of high flow nasal cannula therapy: A laboratory randomized trial in healthy humans.

Clara BianquisCamille Rolland-DebordIsabelle RivalsCaroline Sévoz-CoucheCapucine Morélot-Panzini

Published in: Respirology (Carlton, Vic.) (2023)

HFNT was associated with a statistically significant reduction in the intensity of the sensory and affective components of dyspnoea, independent of oxygen addition. This relief of laboratory dyspnoea could result from a reduction of afferent-reafferent mismatch.

Keyphrases

bipolar disorder
high intensity
extracorporeal membrane oxygenation
respiratory failure
intensive care unit
chronic rhinosinusitis
acute respiratory distress syndrome